A study led by a physician-scientist at the University of Arizona College of Medicine–Tucson’s Sarver Heart Center identified a drug candidate that appears to reverse the progression of a type of heart failure in mouse models, which could lead to expanded treatment options for humans. The results are published in the journal Cell Metabolism.
Go to Source
https://medicalxpress.com/rss-feed/